Health Care: Drugs

ACADIA Pharmaceuticals Inc (ACAD: NASDAQ)

$39.28 n/a | n/a%
02/17/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 39.28
52 Week High 42.49
52 Week Low 17.02
Avg. Daily Vol. (Mil) 2.44
Beta (3 year) 4.63
Share Related Items
Mkt Cap (Mil) 4,757.35
Shares Out (Mil) 121.11
Float (Mil) 74.35
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 15.20
Current Ratio 15.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 883.28
Price/Book 8.23
Price/Cash Flow -20.10
Per Share Data
Earnings -2.14
Sales 0.04
Book Value 4.77
Cash Flow -1.96
Business Summary
ACADIA Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the business of development and commercialization of medicines to address unmet medical needs in central nervous system disorders.
General Information
3611 Valley Centre Drive
Suite 300
San Diego, CA 92130
Industry : Drugs
Sector: Health Care
Employees: 340
CEO: Mr. Stephen R. Davis
Short Interest
Current Month (Mil) 22.99
Previous Month (Mil) 22.14
Short Interest Ratio (Days) 10.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -38.60
Return on Investments -41.30
Gross Margin 98.90
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ACAD

Latest ACAD Headlines from TheStreet

More Financial News for ACAD

Press Releases for ACAD

See All Press Releases

Partner Headlines for ACAD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter